Filippo Biondi

Via Paradisa, 2
Pisa, 56124, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Sodium-glucose cotransporter 2 inhibitors are associated with reduced circulating activin A and modulation of BMP/activin signaling in ischemic cardiomyopathy with high echocardiographic probability of pulmonary hypertension.

Sodium-glucose cotransporter 2 inhibitors are associated with reduced circulating activin A and modulation of BMP/activin signaling in ischemic cardiomyopathy with high echocardiographic probability of pulmonary hypertension.

Journal: GeroScience

Published: June 16, 2026

Prediabetes: Impact on cardiovascular risk and emerging therapeutic strategies.

Prediabetes: Impact on cardiovascular risk and emerging therapeutic strategies.

Journal: Atherosclerosis

Published: May 24, 2026

Genomic and proteogenomic insights into Spontaneous Coronary Artery Dissection (SCAD): A systematic review of emerging multi-omic evidence.

Genomic and proteogenomic insights into Spontaneous Coronary Artery Dissection (SCAD): A systematic review of emerging multi-omic evidence.

Journal: Vascular pharmacology

Published: March 12, 2026

Exercise pulmonary hypertension in asymptomatic patients with HIV infection Insights from the RIGHT-NET registry.

Exercise pulmonary hypertension in asymptomatic patients with HIV infection Insights from the RIGHT-NET registry.

Journal: European journal of internal medicine

Published: February 17, 2026

Exercise testing in chronic thromboembolic pulmonary hypertension and chronic thromboembolic pulmonary disease without pulmonary hypertension: a comprehensive systematic review and meta-analysis.

Exercise testing in chronic thromboembolic pulmonary hypertension and chronic thromboembolic pulmonary disease without pulmonary hypertension: a comprehensive systematic review and meta-analysis.

Journal: European journal of internal medicine

Published: December 01, 2025

Exercise pulmonary hypertension in chronic thromboembolic pulmonary disease without resting pulmonary hypertension: A systematic review and meta-analysis.

Exercise pulmonary hypertension in chronic thromboembolic pulmonary disease without resting pulmonary hypertension: A systematic review and meta-analysis.

Journal: Vascular pharmacology

Published: November 24, 2025

Chronic Thromboembolic Pulmonary Disease: Right Ventricular Function and Pulmonary Hemodynamics in a 4-Year Follow-Up.

Chronic Thromboembolic Pulmonary Disease: Right Ventricular Function and Pulmonary Hemodynamics in a 4-Year Follow-Up.

Journal: International journal of molecular sciences

Published: August 27, 2025

The Potential Role of GLP1-RAs Against Anticancer-Drug Cardiotoxicity: A Scoping Review.

The Potential Role of GLP1-RAs Against Anticancer-Drug Cardiotoxicity: A Scoping Review.

Journal: Journal of clinical medicine

Published: February 15, 2025

Ambrisentan Retains Its Pro-Autophagic Activity on Human Pulmonary Artery Endothelial Cells Exposed to Hypoxia in an In Vitro Model Mimicking Diabetes.

Ambrisentan Retains Its Pro-Autophagic Activity on Human Pulmonary Artery Endothelial Cells Exposed to Hypoxia in an In Vitro Model Mimicking Diabetes.

Journal: Journal of cellular and molecular medicine

Published: January 08, 2025

Sotatercept: New drug on the horizon of pulmonary hypertension.

Sotatercept: New drug on the horizon of pulmonary hypertension.

Journal: Vascular pharmacology

Published: October 10, 2024

Perspectives on Sotatercept in Pulmonary Arterial Hypertension.

Perspectives on Sotatercept in Pulmonary Arterial Hypertension.

Journal: Journal of clinical medicine

Published: October 06, 2024

Not Just CTEPH: A Narrative Review on the Spectrum Approach to Postpulmonary Embolism Conditions.

Not Just CTEPH: A Narrative Review on the Spectrum Approach to Postpulmonary Embolism Conditions.

Journal: Thrombosis and haemostasis

Published: September 19, 2024

Showing 1-12 of 19

Last Updated: 09/26/2026